Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atrion Co. stock logo
ATRI
Atrion
$414.95
$412.89
$274.98
$613.16
$730.31M0.6231,602 shs36,896 shs
Haemonetics Co. stock logo
HAE
Haemonetics
$94.40
+1.1%
$81.95
$70.74
$95.26
$4.79B0.34429,361 shs368,663 shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$99.99
+1.0%
$100.98
$78.28
$212.43
$2.44B0.72194,470 shs165,174 shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$78.97
+2.5%
$74.19
$62.58
$85.62
$4.59B0.91359,416 shs263,069 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atrion Co. stock logo
ATRI
Atrion
0.00%+5.05%+2.38%+22.77%-32.56%
Haemonetics Co. stock logo
HAE
Haemonetics
+1.10%+3.78%+12.53%+23.72%+15.44%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
+0.96%+5.43%-3.26%+9.83%-46.72%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
+2.53%+7.03%+8.40%-0.43%-5.30%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Atrion Co. stock logo
ATRI
Atrion
1.7195 of 5 stars
0.01.02.50.02.63.31.3
Haemonetics Co. stock logo
HAE
Haemonetics
4.0255 of 5 stars
2.32.00.04.32.71.72.5
ICU Medical, Inc. stock logo
ICUI
ICU Medical
3.7876 of 5 stars
2.51.00.03.92.62.51.9
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
4.5917 of 5 stars
3.42.00.03.82.62.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Atrion Co. stock logo
ATRI
Atrion
N/AN/AN/AN/A
Haemonetics Co. stock logo
HAE
Haemonetics
2.50
Moderate Buy$104.6710.88% Upside
ICU Medical, Inc. stock logo
ICUI
ICU Medical
3.00
Buy$123.0023.01% Upside
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
2.89
Moderate Buy$92.7817.48% Upside

Current Analyst Ratings

Latest MMSI, HAE, ICUI, and ATRI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$112.00 ➝ $102.00
5/1/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$98.00 ➝ $100.00
5/1/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$95.00 ➝ $97.00
5/1/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$88.00 ➝ $85.00
4/16/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$98.00
4/12/2024
Haemonetics Co. stock logo
HAE
Haemonetics
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$105.00
4/11/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$88.00
4/11/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$88.00
2/29/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$82.00 ➝ $87.00
2/29/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$81.00 ➝ $88.00
2/29/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$96.00 ➝ $98.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Atrion Co. stock logo
ATRI
Atrion
$169.33M4.31$19.61 per share21.16$138.02 per share3.01
Haemonetics Co. stock logo
HAE
Haemonetics
$1.17B4.10$5.03 per share18.76$16.22 per share5.82
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.26B1.08$15.45 per share6.47$87.96 per share1.14
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$1.26B3.65$4.95 per share15.96$21.34 per share3.70

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Atrion Co. stock logo
ATRI
Atrion
$19.41M$11.0337.62N/A11.46%8.07%7.37%5/13/2024 (Estimated)
Haemonetics Co. stock logo
HAE
Haemonetics
$115.40M$2.4638.3722.262.209.97%22.37%9.71%5/9/2024 (Confirmed)
ICU Medical, Inc. stock logo
ICUI
ICU Medical
-$29.66M-$1.23N/A18.59N/A-1.31%6.35%3.03%5/7/2024 (Confirmed)
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$94.41M$1.7445.3921.642.157.94%15.02%8.83%7/23/2024 (Estimated)

Latest MMSI, HAE, ICUI, and ATRI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Haemonetics Co. stock logo
HAE
Haemonetics
$0.88N/A-$0.88N/AN/AN/A  
5/7/2024N/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$0.8350N/A-$0.8350N/AN/AN/A  
4/30/2024Q1 2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.71$0.77+$0.06$1.06$315.57 million$323.51 million    
2/29/2024Q4 2023
Atrion Co. stock logo
ATRI
Atrion
N/A$3.65+$3.65$3.65N/A$43.58 million
2/28/2024Q4 2023
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.77$0.81+$0.04$1.15$320.66 million$324.52 million    
2/27/2024Q4 2023
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$0.85$1.24+$0.39$3.19$564.77 million$587.86 million
2/8/202412/31/2023
Haemonetics Co. stock logo
HAE
Haemonetics
$0.94$1.04+$0.10$1.47$320.84 million$336.20 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Atrion Co. stock logo
ATRI
Atrion
$8.802.12%+9.65%79.78%21 Years
Haemonetics Co. stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
N/AN/AN/AN/AN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
N/AN/AN/AN/AN/A

Latest MMSI, HAE, ICUI, and ATRI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/27/2024
Atrion Co. stock logo
ATRI
Atrion
Quarterly$2.202.42%3/14/20243/15/20243/29/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Atrion Co. stock logo
ATRI
Atrion
N/A
9.09
2.57
Haemonetics Co. stock logo
HAE
Haemonetics
0.91
2.92
1.76
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.74
2.53
1.06
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.65
6.03
3.95

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Atrion Co. stock logo
ATRI
Atrion
66.19%
Haemonetics Co. stock logo
HAE
Haemonetics
99.67%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
96.10%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
99.66%

Insider Ownership

CompanyInsider Ownership
Atrion Co. stock logo
ATRI
Atrion
22.82%
Haemonetics Co. stock logo
HAE
Haemonetics
1.79%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
6.70%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
3.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Atrion Co. stock logo
ATRI
Atrion
7121.76 million1.36 millionNot Optionable
Haemonetics Co. stock logo
HAE
Haemonetics
3,03450.79 million49.88 millionOptionable
ICU Medical, Inc. stock logo
ICUI
ICU Medical
14,00024.36 million22.73 millionOptionable
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
6,95058.11 million55.96 millionOptionable

MMSI, HAE, ICUI, and ATRI Headlines

SourceHeadline
Needham & Company LLC Trims Merit Medical Systems (NASDAQ:MMSI) Target Price to $85.00Needham & Company LLC Trims Merit Medical Systems (NASDAQ:MMSI) Target Price to $85.00
americanbankingnews.com - May 4 at 6:14 AM
Piper Sandler Boosts Merit Medical Systems (NASDAQ:MMSI) Price Target to $97.00Piper Sandler Boosts Merit Medical Systems (NASDAQ:MMSI) Price Target to $97.00
americanbankingnews.com - May 4 at 5:36 AM
Barrington Research Boosts Merit Medical Systems (NASDAQ:MMSI) Price Target to $100.00Barrington Research Boosts Merit Medical Systems (NASDAQ:MMSI) Price Target to $100.00
americanbankingnews.com - May 4 at 5:36 AM
Merit Medical Systems, Inc. (NASDAQ:MMSI) Forecasted to Post FY2024 Earnings of $3.35 Per ShareMerit Medical Systems, Inc. (NASDAQ:MMSI) Forecasted to Post FY2024 Earnings of $3.35 Per Share
americanbankingnews.com - May 4 at 3:26 AM
Merit Medical Systems, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This YearMerit Medical Systems, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
finance.yahoo.com - May 3 at 10:31 AM
Brokers Set Expectations for Merit Medical Systems, Inc.s FY2024 Earnings (NASDAQ:MMSI)Brokers Set Expectations for Merit Medical Systems, Inc.'s FY2024 Earnings (NASDAQ:MMSI)
marketbeat.com - May 3 at 9:59 AM
Merit Medical Systems (NASDAQ:MMSI) Price Target Cut to $102.00Merit Medical Systems (NASDAQ:MMSI) Price Target Cut to $102.00
americanbankingnews.com - May 3 at 5:18 AM
Merit Health Wesley hires new chief executive officerMerit Health Wesley hires new chief executive officer
msn.com - May 2 at 10:35 AM
Merit Medical Systems First Quarter 2024 Earnings: Beats ExpectationsMerit Medical Systems First Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - May 2 at 10:35 AM
Merit Medical Systems (NASDAQ:MMSI) Rating Increased to Buy at StockNews.comMerit Medical Systems (NASDAQ:MMSI) Rating Increased to Buy at StockNews.com
americanbankingnews.com - May 2 at 5:16 AM
Men of Merit: UCI HealthMen of Merit: UCI Health
msn.com - May 1 at 6:56 PM
The Analyst Landscape: 11 Takes On Merit Medical SystemsThe Analyst Landscape: 11 Takes On Merit Medical Systems
markets.businessinsider.com - May 1 at 6:56 PM
Merit Medical Systems (NASDAQ:MMSI) PT Lowered to $102.00Merit Medical Systems (NASDAQ:MMSI) PT Lowered to $102.00
marketbeat.com - May 1 at 3:06 PM
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Inari Medical (NARI) and Tenet Healthcare (THC)Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Inari Medical (NARI) and Tenet Healthcare (THC)
markets.businessinsider.com - May 1 at 1:55 PM
Bank of America Securities Keeps Their Hold Rating on Merit Medical Systems (MMSI)Bank of America Securities Keeps Their Hold Rating on Merit Medical Systems (MMSI)
markets.businessinsider.com - May 1 at 1:55 PM
Merit Medical (MMSI) Q1 Earnings Top Estimates, Margins UpMerit Medical (MMSI) Q1 Earnings Top Estimates, Margins Up
zacks.com - May 1 at 1:50 PM
Merit Medical Systems (NASDAQ:MMSI) Issues Quarterly  Earnings Results, Beats Expectations By $0.06 EPSMerit Medical Systems (NASDAQ:MMSI) Issues Quarterly Earnings Results, Beats Expectations By $0.06 EPS
marketbeat.com - May 1 at 8:38 AM
Merit Medical Systems Inc (MMSI) Q1 2024 Earnings Call Transcript Highlights: Strong ...Merit Medical Systems Inc (MMSI) Q1 2024 Earnings Call Transcript Highlights: Strong ...
finance.yahoo.com - May 1 at 3:54 AM
MMSI Stock Earnings: Merit Medical Systems Beats EPS, Beats Revenue for Q1 2024MMSI Stock Earnings: Merit Medical Systems Beats EPS, Beats Revenue for Q1 2024
markets.businessinsider.com - April 30 at 10:54 PM
Merit Medical Systems (NASDAQ:MMSI) Releases FY 2024 Earnings GuidanceMerit Medical Systems (NASDAQ:MMSI) Releases FY 2024 Earnings Guidance
marketbeat.com - April 30 at 8:29 PM
Merit Medical (MMSI) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesMerit Medical (MMSI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
zacks.com - April 30 at 7:31 PM
Merit Medical (MMSI) Beats Q1 Earnings and Revenue EstimatesMerit Medical (MMSI) Beats Q1 Earnings and Revenue Estimates
zacks.com - April 30 at 6:35 PM
Merit Medical: Q1 Earnings SnapshotMerit Medical: Q1 Earnings Snapshot
sfgate.com - April 30 at 5:53 PM
Merit Medical Reports Results for First Quarter Ended March 31, 2024Merit Medical Reports Results for First Quarter Ended March 31, 2024
finance.yahoo.com - April 30 at 5:53 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Atrion logo

Atrion

NASDAQ:ATRI
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Haemonetics logo

Haemonetics

NYSE:HAE
Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system, and Donor360. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot including collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
ICU Medical logo

ICU Medical

NASDAQ:ICUI
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
Merit Medical Systems logo

Merit Medical Systems

NASDAQ:MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.